Brooks P M, Buchanan W W
Curr Med Res Opin. 1976;4(1):94-100. doi: 10.1185/03007997609109288.
The authors review the trials carried out on azapropazone in rheumatoid arthritis and other rheumatoid conditions. They comment that in terms of efficacy azapropazone would appear to be a useful non-steroidal anti-inflammatory analgesic which compares favourably with other established antirheumatic agents against which it has been tested. Its main advantages are its low incidence of side-effects and the fact that in the majority of the trials reported azapropazone treatment was preferred by patients to that with other agents.
作者回顾了关于阿扎丙宗治疗类风湿性关节炎及其他类风湿病症的试验。他们评论道,就疗效而言,阿扎丙宗似乎是一种有用的非甾体抗炎镇痛药,与其他已被测试的既定抗风湿药物相比具有优势。其主要优点是副作用发生率低,且在大多数报道的试验中,患者更喜欢阿扎丙宗治疗而非其他药物治疗。